These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 9699129)
1. Serum FSH bioactivity and inhibin levels in patients with gonadotropin secreting and nonfunctioning pituitary adenomas. Borgato S; Persani L; Romoli R; Cortelazzi D; Spada A; Beck-Peccoz P J Endocrinol Invest; 1998 Jun; 21(6):372-9. PubMed ID: 9699129 [TBL] [Abstract][Full Text] [Related]
2. Impaired estrogen-induced negative feedback on gonadotropin secretion in patients with gonadotropin-secreting and nonfunctioning pituitary adenomas. Lania A; Gangi E; Romoli R; Losa M; Travaglini P; Meringolo D; Ambrosi B; Faglia G; Beck-Peccoz P; Spada A Eur J Clin Invest; 2002 May; 32(5):335-40. PubMed ID: 12027873 [TBL] [Abstract][Full Text] [Related]
3. Immunodetection of glycoprotein hormone subunits in nonfunctioning and glycoprotein hormone-secreting pituitary adenomas. Saccomanno K; Bassetti M; Lania A; Losa M; Faglia G; Spada A J Endocrinol Invest; 1997 Feb; 20(2):59-64. PubMed ID: 9125484 [TBL] [Abstract][Full Text] [Related]
4. Abnormal response of luteinizing hormone beta subunit to thyrotrophin-releasing hormone in patients with non-functioning pituitary adenoma. Gil-del-Alamo P; Pettersson KS; Saccomanno K; Spada A; Faglia G; Beck-Peccoz P Clin Endocrinol (Oxf); 1994 Nov; 41(5):661-6. PubMed ID: 7828356 [TBL] [Abstract][Full Text] [Related]
5. Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine. Kwekkeboom DJ; de Jong FH; Lamberts SW J Clin Endocrinol Metab; 1989 Jun; 68(6):1128-35. PubMed ID: 2542356 [TBL] [Abstract][Full Text] [Related]
6. Effect of aging on serum gonadotropin levels in healthy subjects and patients with nonfunctioning pituitary adenomas. Vaninetti S; Baccarelli A; Romoli R; Fanelli M; Faglia G; Spada A Eur J Endocrinol; 2000 Feb; 142(2):144-9. PubMed ID: 10664522 [TBL] [Abstract][Full Text] [Related]
7. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas. Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365 [TBL] [Abstract][Full Text] [Related]
8. In vitro secretion of FSH by cultured clinically nonfunctioning and gonadotroph pituitary adenomas is directly correlated with locally produced levels of activin A. Wessels HT; Hofland LJ; van der Wal R; van Gastel L; van Koetsveld PM; de Herder WW; de Jong FH Clin Endocrinol (Oxf); 2001 Apr; 54(4):485-92. PubMed ID: 11318784 [TBL] [Abstract][Full Text] [Related]
9. Gonadotroph cell adenomas of the pituitary. Snyder PJ Endocr Rev; 1985; 6(4):552-63. PubMed ID: 2416559 [TBL] [Abstract][Full Text] [Related]
10. Serum inhibins A and B fall differentially as FSH rises in perimenopausal women. Burger HG; Cahir N; Robertson DM; Groome NP; Dudley E; Green A; Dennerstein L Clin Endocrinol (Oxf); 1998 Jun; 48(6):809-13. PubMed ID: 9713572 [TBL] [Abstract][Full Text] [Related]
11. An inverse relationship exists between seminal plasma inhibin and serum follicle-stimulating hormone in man. Scott RS; Burger HG J Clin Endocrinol Metab; 1981 Apr; 52(4):796-803. PubMed ID: 6782118 [TBL] [Abstract][Full Text] [Related]
12. The effect of thyrotropin-releasing hormone on gonadotropin and free alpha-subunit secretion in patients with acromegaly and functionless pituitary tumors. Popovic V; Damjanovic S Thyroid; 1998 Oct; 8(10):935-9. PubMed ID: 9827662 [TBL] [Abstract][Full Text] [Related]
13. Effects of oestrogen treatment on serum gonadotrophin bioactivity, immunoreactivity and isohormone distribution, and on immunoreactive inhibin levels, in prostatic cancer patients. Matikainen T; Haavisto AM; Permi J; de Kretser D; Huhtaniemi I Clin Endocrinol (Oxf); 1994 Jun; 40(6):743-50. PubMed ID: 8033364 [TBL] [Abstract][Full Text] [Related]
14. Free luteinizing-hormone beta-subunit in normal subjects and patients with pituitary adenomas. Chanson P; Pantel J; Young J; Couzinet B; Bidart JM; Schaison G J Clin Endocrinol Metab; 1997 May; 82(5):1397-402. PubMed ID: 9141523 [TBL] [Abstract][Full Text] [Related]
15. Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. Anawalt BD; Bebb RA; Matsumoto AM; Groome NP; Illingworth PJ; McNeilly AS; Bremner WJ J Clin Endocrinol Metab; 1996 Sep; 81(9):3341-5. PubMed ID: 8784094 [TBL] [Abstract][Full Text] [Related]
16. A spontaneous and severe hyperstimulation of the ovaries revealing a gonadotroph adenoma. Christin-Maitre S; Rongières-Bertrand C; Kottler ML; Lahlou N; Frydman R; Touraine P; Bouchard P J Clin Endocrinol Metab; 1998 Oct; 83(10):3450-3. PubMed ID: 9768644 [TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-releasing hormone agonists are unsuccessful in reducing tumoral gonadotropin secretion in two patients with gonadotropin-secreting pituitary adenomas. Sassolas G; Lejeune H; Trouillas J; Forest MG; Claustrat B; Lahlou N; Loras B J Clin Endocrinol Metab; 1988 Jul; 67(1):180-5. PubMed ID: 2967850 [TBL] [Abstract][Full Text] [Related]
18. Gonadotroph adenomas in men produce biologically active follicle-stimulating hormone. Galway AB; Hsueh AJ; Daneshdoost L; Zhou MH; Pavlou SN; Snyder PJ J Clin Endocrinol Metab; 1990 Oct; 71(4):907-12. PubMed ID: 2119391 [TBL] [Abstract][Full Text] [Related]
20. Inhibin and follicle-stimulating hormone levels in gonadotroph adenomas: evidence of a positive correlation with tumour volume in men. Lahlou N; Le Nestour E; Chanson P; Seret-Bégué D; Bouchard P; Roger M; Warnet A Clin Endocrinol (Oxf); 1993 Mar; 38(3):301-9. PubMed ID: 8458102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]